Ocean Biomedical, Inc. cotiza a 0.00 USD y tiene una capitalización bursátil de $46473. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States. The company's oncology product candidates include OCX-253 anti-Chi3l1 Single-target mAb and OCX-410 anti-Chi3l1/PD-1 Bi-specific antibody f…
| Periodo | 2024-04 | 2023-08 | 2023-05 |
|---|---|---|---|
| Real | $-0.52 | $-0.41 | $-0.27 |
| Estimado | $-0.15 | $-0.19 | $-0.17 |
| Sorpresa | -246.7% | -115.8% | -58.8% |
| Métrica | OCEA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | -1051.0% | -32.0% | -1019.0% |
| Current Ratio | 0.02 | 2.84 | -2.82 |
| Debt / Equity | — | 0.28 | — |